adishum: adishum

In pharmaverseadamjnj: J&J Innovative Medicine ADaM Test Data

adishum

Description

adishum modified from pharmaverseadam

Usage

adishum

Format

A data frame with 10922 rows and 66 variables:

USUBJID

Unique Subject Identifier

VISITNUM

Visit Number

PARAMCD

Parameter Code

ISTESTCD

Immunogenicity Test/Exam Short Name

PARCAT1

Parameter Category 1

PARAM

Parameter Description

ISSEQ

Sequence Number

ISBDAGNT

Binding Agent

ISSTRESC

Character Result/Finding in Std Format

ISSTRESN

Numeric Results/Findings in Std. Units

ISNAM

Vendor Name

VISIT

Visit Name

ISDTC

Date/Time of Collection

ADTM

Analysis Datetime

PARQUAL

Parameter Qualifier

AVAL

Analysis Value

AVALC

Analysis Value (C)

AVALCAT1

Analysis Value Category 1

IMEVFL

IS Evaluable Population Flag

AVISITN

Analysis Visit (N)

AVISIT

Analysis Visit

VISITDY

Planned Study Day of Visit

ADT

Analysis Date

ADY

Analysis Relative Day

ABLFL

Baseline Record Flag

ANL01FL

Analysis Flag 01

ANL02FL

Analysis Flag 02

ANL03FL

Analysis Flag 03-Inf SR

ANL04FL

Analysis Flag 04-Severe Inf SR

ANL05FL

Analysis Flag 05-Serious Inf SR

ANL06FL

Analysis Flag 06-Infus SR - DC

ANL07FL

Analysis Flag 07-Inj SR

ANL08FL

Analysis Flag 08-Severe Inj SR

ANL09FL

Analysis Flag 09-Serious Inj SR

ANL10FL

Analysis Flag 10-Inject SR - DC

ANL11FL

Analysis Flag 11-grade >=3 Inf SR

ANL12FL

Analysis Flag 12-grade >=3 Inj SR

ATPT

Analysis Timepoint

ATPTN

Analysis Timepoint (N)

INFUSPN

Number of Placebo infusions

INFUSPRN

Placebo infusions with reaction

INFUSAN

Number of Active Drug infusions

INFUSARN

Active Drug infusions with reaction

INJECPN

Number of Placebo injections

INJECPRN

Placebo injections with reaction

INJECAN

Number of Active Drug injections

INJECARN

Active Drug injections with reaction

DTL

Drug Tolerance Limit

ADATRES

Treatment-emergent ADA Subject Status

NABSTAT

NAB Status

ADATREPT

TE ADA Positive Subject Peak Titer

STUDYID

Study Identifier

SUBJID

Subject Identifier for the Study

SITEID

Study Site Identifier

AGE

Age

SEX

Sex

RACE

Race

IMFL

Immunogenicity Population Flag

SAFFL

Safety Population Flag

TRTSDT

Date of First Exposure to Treatment

TRTSDTM

Datetime of First Exposure to Treatment

TRT01P

Planned Treatment for Period 01

TRT01PN

Planned Treatment for Period 01 (N)

TRT01A

Actual Treatment for Period 01

TRT01AN

Actual Treatment for Period 01 (N)

TRTA

Actual Treatment

Source

data from pharmaverseadam.

See Also

adae adaecomp adaeocmq adagocmq adcm addili addisp adeg adex adexsum adishum adlb adpc adsl adslcomp adttesaf advs# nolint

Examples

 head(data("adishum"))

pharmaverseadamjnj documentation built on Sept. 28, 2026, 5:10 p.m.